Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

2.80
Delayed Data
As of 11:25am ET
 +0.07 / +2.56%
Today’s Change
1.03
Today|||52-Week Range
7.61
+8.53%
Year-to-Date

Today’s Trading

Previous close2.73
Today’s open2.76
Day’s range2.70 - 2.98
Volume226,772
Average volume (3 months)266,203
Market cap$118.4M
Data as of 11:25am ET, 06/18/2019

Growth & Valuation

Earnings growth (last year)-249.68%
Earnings growth (this year)+36.68%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)-40.94%
P/E ratioNM
Price/Sales0.93
Price/Book42.55

Competitors

 Today’s
change
Today’s
% change
MDWDMediwound Ltd-0.15-4.01%
TRVNTrevena Inc0.000.00%
ABUSArbutus Biopharma Co...-0.05-2.75%
CEMIChembio Diagnostics ...0.000.00%
Data as of 11:39am ET, 06/18/2019

Financials

Next reporting dateAugust 6, 2019
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$103.2M
Annual profit (last year)-$95.2M
Net profit margin-92.29%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Gregory J. Divis
Chief Financial Officer &
Senior Vice President
Michael F. Kanan
Corporate headquarters
Dublin, Dublin

Forecasts